Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-4-2
|
pubmed:abstractText |
The authors analyzed 27 breakthrough bacteremias occurring during ofloxacin prophylaxis in afebrile neutropenia over 7 years in 9989 admissions and 979 bacteremic and fungemic episodes in a National Cancer Center in Bratislava, Slovak Republic. The most frequently isolated organisms in breakthrough bacteremias were gram-positive (71.3%), mainly coagulase-negative staphylococci (41.3%), enterococci (9.2%) and Corynebacteria (9.2%), followed by gram-negative rods-Pseudomonas aeruginosa (13.2%) and Stenotrophomonas maltophilia (9.2%). The outcome of breakthrough bacteremias during ofloxacin prophylaxis was not associated with the underlying disease, neutropenia, catheter insertion or resistance, but only with multiple risk factors. A higher failure rate was observed in those patients having a catheter infected with a resistant organism and during neutropenia. No patients with Hickman catheter were included in the study. Patients with mixed breakthrough bacteremia due to gram-negative and gram-positive organisms had higher failure rates than those with monomicrobial bacteremia. Catheter extraction and rapid institution of intravenous antibiotics in combination should be administered in breakthrough bacteremia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1120-009X
|
pubmed:author |
pubmed-author:DemitrovicovaAA,
pubmed-author:DrgonaLL,
pubmed-author:HelpianskaLL,
pubmed-author:IlavskaII,
pubmed-author:KorelRR,
pubmed-author:KrcmeryVVJr,
pubmed-author:KukuckovaEE,
pubmed-author:LackaJJ,
pubmed-author:OravcovaEE,
pubmed-author:PichnaPP,
pubmed-author:RusnakovaVV,
pubmed-author:SpanikSS,
pubmed-author:StudenaMM,
pubmed-author:TruplJJ
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
387-93
|
pubmed:dateRevised |
2009-8-4
|
pubmed:meshHeading |
pubmed-meshheading:8957720-Bacteremia,
pubmed-meshheading:8957720-Disease Outbreaks,
pubmed-meshheading:8957720-Fungemia,
pubmed-meshheading:8957720-Humans,
pubmed-meshheading:8957720-Incidence,
pubmed-meshheading:8957720-Microbial Sensitivity Tests,
pubmed-meshheading:8957720-Neoplasms,
pubmed-meshheading:8957720-Ofloxacin,
pubmed-meshheading:8957720-Opportunistic Infections,
pubmed-meshheading:8957720-Retrospective Studies,
pubmed-meshheading:8957720-Risk Factors,
pubmed-meshheading:8957720-Slovakia,
pubmed-meshheading:8957720-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
|
pubmed:affiliation |
Dept. of Medicine, University of Trnava, Bratislava, Slovak Republic.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|